Sartorius Osake

Sartorius EBITDA

EBITDA (Tulos ennen korkoja, veroja ja poistoja) yhtiöstä Sartorius (SRT.DE) 12.8.2026 päivämäärällä on 651,40 M EUR. Edellisenä vuonna EBITDA (Tulos ennen korkoja, veroja ja poistoja) oli 437,20 M EUR — muutos 48,99 % (korkeampi).

EBITDA

651,40 MEUR

YoY

48,99%

Viimeksi päivitetty:

EBITDA (Tulos ennen korkoja, veroja ja poistoja) yhtiöstä Sartorius on 2026 651,40 M EUR. EBITDA (Tulos ennen korkoja, veroja ja poistoja) yhtiöstä Sartorius oli 2025 437,20 M EUR. Se laskee 48,99% korkeampi edelliseen vuoteen verrattuna.
Access this data via the Eulerpool API

Sartorius Osakeanalyysi

Mitä Sartorius tekee? Sartorius AG is a globally operating company specializing in the development and manufacturing of laboratory equipment and process technologies. It was founded in 1870 by industrialist and entrepreneur Florenz Sartorius in Göttingen, Germany. The company initially focused on the sale of scales, weights, and measuring instruments but has since expanded and diversified its product line. Today, Sartorius AG is a world leader in the bioprocessing and laboratory equipment sectors and is known for its innovative products and procedures. The company's business model revolves around the development of high-tech products for applications in biotechnology, pharmaceuticals, and the food industry. It operates in two main business segments: Bioprocess Solutions and Lab Products & Services. The Bioprocess Solutions segment provides solutions and services for biopharmaceutical production, including filtration, fermentation, fluid management, and cell cultures. The products in this segment are typically disposable consumables used in the production of biopharmaceutical agents. The Lab Products & Services segment offers a wide range of laboratory equipment, from scales and microbiology equipment to ultrafiltration devices. These instruments are used by researchers and scientists in academic, industrial, and pharmaceutical laboratories worldwide. Furthermore, an important part of Sartorius' portfolio includes bioreactors and fermenters. These specialized devices are used for cultivating cells and microorganisms and are particularly important in biotechnology and vaccine production. Sartorius has established itself as a leader in this field through its innovative and high-performance products. In addition to the pharmaceutical, biotechnology, and laboratory sectors, Sartorius is also active in environmental technology. The company provides products and services for water analysis and purification, which are in demand in industries such as pharmaceuticals, food production, and environmental analysis due to their precise and reliable results. Sartorius demonstrates its innovation through the use of technologies such as machine learning and artificial intelligence. For example, the company offers the "Ambr" solution for fast and reliable modeling of production scenarios for biopharmaceutical agents. Machine learning techniques are employed to generate more data and make better decisions. Overall, Sartorius AG is a global company with a wide range of products and services for the biotechnology, pharmaceutical, chemical, and food industries. The company's innovation is evident in its continuous advancement of procedures, technologies, and products. With a strong market position and clear strategic direction, Sartorius will continue to be an important player in the industry and support the work of researchers and scientists worldwide with its high-performance products. Sartorius on yksi Eurpooliin suosituimmista yhtiöistä.

Usein kysytyt kysymykset Sartorius osakkeesta

Yhtiön Sartorius EBITDA (Tulos ennen korkoja, veroja ja poistoja) on 651,40 M EUR vuonna 2026.

EBITDA (Tulos ennen korkoja, veroja ja poistoja) yhtiöstä Sartorius muuttui arvosta 437,20 M EUR arvoon 651,40 M EUR, mikä edustaa 48,99 % muutosta. Arvo on korkeampi kuin edellisenä vuonna.

Eurpoolissa voit löytää EBITDA (Tulos ennen korkoja, veroja ja poistoja) Sartorius:n täydellisen historiallisen kehityksen vuodesta 2006 lähtien – vuotuisten arvojen, kaavioiden ja yksityiskohtaisen analyysin kanssa.

EBITDA mittaa operatiivista suorituskykyä ennen rahoitusrakenteen, veroympäristön ja muiden kuin käteispoisto-osuuksien vaikutusta.

EBITDA = EBIT + Poistot

EBITDA (Tulos ennen korkoja, veroja ja poistoja):n EUR on sijoittajille tärkeä tekijä. Muutokset tässä tunnusluvussa voivat signaloida parantuvia tai heikentyneitä perustekijöitä, mikä vaikuttaa suoraan osakekurssiin. Eulerpoolissa voit seurata EBITDA (Tulos ennen korkoja, veroja ja poistoja):n Sartorius historiallisesti ja reaaliajassa.

Access this data via the Eulerpool API

Tuloslaskelma — Sartorius

Kaikki tunnusluvut — Sartorius